ONDCP Seal



PolicyPolicy

The National Drug Control Strategy:
2001 Annual Report


  Table of Contents

    Foreword by General Barry McCaffrey

  1. Annual Report and the National Drug Control Strategy: An Overview
    Annual Report on Implementing the
        National Drug Control Strategy
    Mandate for a National Drug Control Strategy
    Evolution of the National Drug Control Strategy
    The National Response to Drug Abuse
    The Public-Health Dimension of Substance Abuse
    Public-Safety Dimensions of Substance Abuse
    Law Enforcement
    International Initiatives
    Research-Based Policy
    Goals of the National Drug Control Strategy
    Drug Control is a Continuous Challenge
    Endnotes

  2. America’s Drug Use Profile
    Youth Drug Use Trends
    Marijuana
    Cocaine
    Heroin
    Methamphetamine
    MDMA
    Inhalants
    Other Illicit Substances
    The Link Between Drugs and Crime
    The Consequences of Illegal Drug Use
    Performance Measures of Effectiveness
    Endnotes

  3. Report on Programs and Initiatives
    1. Initiatives to Prevent Drug Use
      The Central Role of Parents
      Substance-Abuse Prevention in Early Childhood
      National Youth Anti-Drug Media Campaign
      Safe and Drug-Free Schools and Communities
      After-School Initiatives
      Drug-Free Communities
      Housing Initiatives
      Prevention through Service Alliance
      Workplace Prevention Initiatives
      Preventing Drug Use Through Athletics and Drug Free Sports
      Faith Initiative
      Drug Prevention through Law Enforcement
      Legalization, Decriminalization, and Harm Reduction
      The Use of Marijuana as Medicine
      “Industrial” Hemp
      Child Welfare Initiatives
      Welfare-to-Work Initiatives
      Youth Tobacco Initiative
      Youth Alcohol Use Prevention
      Comprehensive Prevention Systems
      Centers for the Application of Prevention Technologies (CAPTs)
      Decision Support System (DSS)
    2. Treating Addicted Individuals
      Drug Addition Treatment is Effective
      Research on Addiction
      Status of Drug Treatment
      No Wrong Door
      Services for Women
      Substance Abuse and Co-occurring Mental Disorders
      Moving Addiction Treatment into the Mainstream of Healthcare
      Parity for Substance-Abuse Treatment
      Medications for Drug Addiction
      Behavioral Treatment Initiative
      National Drug Abuse Treatment Clinical Trials Network
      Practice Research Collaboratives Program (PRC)
      Treatment Research and Evaluation
      Research into the Mechanisms of Addiction
      Reducing Infectious Disease Among Injecting Drug Users
      Training for Substance-Abuse Professionals
      Providing Services for Vulnerable Populations
      Family Drug Treatment Courts
      The National Treatment Plan Initiative
    3. Breaking the Cycle of Drugs and Crime
      Substance Abuse Treatment for Incarcerated Offenders
      Providing Treatment in Prisons and Jails
      Dual Diagnosis/Dual Disorder
      Drug-Free Prison Zone
      Operating Standards for Prison-Based Therapeutic Communities (TCs)
      Substance-Abuse Treatment Provided with Community Supervision
      Criminal Justice Treatment Networks
      Drug Courts
      Treatment Accountability for Safer Communities (TASC)
      Breaking the Cycle (BTC)
      Zero Tolerance Drug Supervision Initiative
      Initiatives Currently Underway
      National Assembly
      Juvenile Justice
      System Integration
    4. Enforcing the Nation’s Laws
      Law-Enforcement Coordination
      Assisting State and Local Agencies
      High Intensity Drug Trafficking Area (HIDTA)
      Community-Oriented Policing
      Organized Crime Drug Enforcement Task Forces (OCDETF)
      Weed and Seed
      Anti Money-Laundering Initiatives
      Enhancing Asset Forfeiture
      Preventing Chemical Diversion
      Drugs and Crime on America’s Public Lands
      Intelligence Sharing
      ONDCP’s Counterdrug Technology Assessment Center
      Law Enforcement’s Ability to Keep Pace with Trafficker Technology
      Targeting Gangs and Violence
      Equitable Sentencing Policies
      State Drug Laws
    5. Shielding U.S. Borders from the Drug Threat
      Organizing Against the Drug Threat
      Drug Trafficking Across the Southwest Border
      All Borders
      U.S. Seaports
      Organizing for Success
      Border Coordination Initiative (BCI)
      Port and Border Security Initiative
      Working with the Private Sector to Keep Drugs Out of America
      Harnessing Technology
      Review of Counterdrug Intelligence Architecture
    6. Reducing the Supply of Illegal Drugs
      Breaking Cocaine Sources of Supply
      President Pastrana’s “Plan Colombia” and the U.S.-Colombia Initiative
      The Use of Mycoherbicides
      Breaking Heroin Sources of Supply
      Countering the Spread of Synthetic Drugs
      Reducing Domestic Marijuana Cultivation
      Interdiction Operations
      Forward Operating Location Architechure
      Operations in the Transit Zone
      Targeting International Drug-Trafficking Organizations
      Efforts to Control Precursor Chemicals
      International Money Laundering and Asset Forfeiture
      Certification for Major Illicit Drug-Producing and Transit Countries
      International Drug-Control Cooperation
      Bilateral Cooperation with Mexico
      Regional Drug Control in the Western Hemisphere and the
          Multilateral Evaluation Mechanism
      Drug-Control Efforts through Other International Organizations
      Promoting International Demand Reduction
      Supporting Democracy and Human Rights
      Reducing Corruption
    Endnotes

  4. The National Drug Control Budget
    Overview
    Historical Perspective
    Federal Funding Priorities
    Drug Budget Accounting Improvements

  5. Consultation
    Consultation with Congress
    Consultation with National Drug-Control Program Agencies
    Consultation with State and Local Officials
    Consultation with Private Citizens and Organizations
    Consultation with Representatives of Foreign Governments and
        International Organizations
    Consultation with Non-Governmental Organizations

Appendix: Drug-Related Data
  Tables

Glossary: Abbreviations and Acronyms